Eyenovia reports FY2022 net loss $28.0M; Mydcombi PDUFA date May 8, 2023

HYPERION DEFI, INC.

Net loss $28.0M ($0.83/share) for FY2022 vs $12.8M loss in FY2021; Q4 loss $6.1M.
Cash and equivalents $22.9M at Dec 31, 2022, down from $27.3M at Dec 31, 2021.
FDA accepted Mydcombi NDA; PDUFA action target date May 8, 2023.
Positive Phase 3 results for Microline (presbyopia); FDA feedback outlines clear path forward.
Co-development agreement with Formosa Pharmaceuticals to combine Optejet with APNT nanoparticle platform.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HYPERION DEFI, INC. reported fourth quarter ended December 31, 2022 results: net income net loss was approximately $[6.1] million, or $[0.17] per share, EPS $[0.17] per share.

Period: fourth quarter ended December 31, 2022
Net income: net loss was approximately $[6.1] million, or $[0.17] per share
EPS: $[0.17] per share
Result: reported results

Exact text from the filing

For the fourth quarter of 2022, net loss was approximately $[6.1] million, or $[0.17] per share compared to a net income of approximately $3.0 million, or $0.11 per share, for the fourth quarter of 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HYPERION DEFI, INC. reported fiscal year ended December 31, 2022 results: net income net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o, EPS $[0.83] per share.

Period: fiscal year ended December 31, 2022
Net income: net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o
EPS: $[0.83] per share
Result: reported results

Exact text from the filing

For the full-year 2022, net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares outstanding, and this compares to a net loss of approximately $[12.8] million, or $[0.49] per share, for the full year 2021 on approximately 26.3 million weighted average shares outstanding.

View on SEC.gov

Browse all earnings releases →

HYPERION DEFI, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-039153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.